These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6600389)

  • 1. Acute tumor lysis in T-cell leukemia induced by amsacrine.
    Vogler WR; Morris JG; Winton EF
    Arch Intern Med; 1983 Jan; 143(1):165-6. PubMed ID: 6600389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
    Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
    Arlin ZA; Sklaroff RB; Gee TS; Kempin SJ; Howard J; Clarkson BD; Young CW
    Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
    Arlin ZA
    Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersensitivity reactions to amsacrine.
    Perry DJ; Weiss RB; Hoth DF
    Cancer Treat Rep; 1985 Feb; 69(2):199-201. PubMed ID: 3155993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrocardiogram abnormalities induced by amsacrine.
    Weiss RB; Moquin D; Adams JD; Griffin JD; Zimbler H
    Cancer Chemother Pharmacol; 1983; 10(2):133-4. PubMed ID: 6572570
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of amsacrine gluconate in refractory leukemia.
    Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
    Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of AMSA in acute leukemia.
    Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
    Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal hepatotoxicity associated with AMSA therapy.
    Appelbaum FR; Shulman HM
    Cancer Treat Rep; 1982 Oct; 66(10):1863-65. PubMed ID: 6957265
    [No Abstract]   [Full Text] [Related]  

  • 12. AMSA therapy for children with lymphoblastic malignancy.
    Hutter JJ; Meyskens FL
    Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of amsacrine in patients with acute leukemia at first relapse.
    Danova M; Riccardi A; Invernizzi R; Ucci G; Girino M; Montecucco CM; Cresci R; Ascari E; Mauri C
    Haematologica; 1985; 70(6):545-6. PubMed ID: 3938435
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac arrhythmia associated with AMSA in a child: a Southwest Oncology Group Study.
    Riela AR; Kimball JC; Patterson RB
    Cancer Treat Rep; 1981; 65(11-12):1121-3. PubMed ID: 6945913
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypocalcemia and hyperuricemia during treatment of acute lymphoblastic leukemia in childhood].
    Armata J; Depowska T
    Pol Tyg Lek; 1974 Jul; 29(30):1309-10. PubMed ID: 4527390
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor lysis syndrome, DIC and interstitial pneumonia after treatment with prednisolone and melphalan in a patient with acute monocytic leukemia with tumor formation].
    Fukuda M; Inaba R
    Rinsho Ketsueki; 1987 Apr; 28(4):553-8. PubMed ID: 3476765
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of amsacrine, an investigational antineoplastic agent.
    Grove WR; Fortner CL; Wiernik PH
    Clin Pharm; 1982; 1(4):320-6. PubMed ID: 6764391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Berkowitz I; Kennedy BJ; Green M; Herschkopf R; Rafla S
    Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
    Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
    Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities in adult acute lymphoblastic leukaemia (Burkitt cell type): case report.
    Romeril KR; Concannon AJ; Biggs JC
    N Z Med J; 1981 Oct; 94(694):299-301. PubMed ID: 6948195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.